McKechnie Duncan sold VRTX
March 4, 2026 · Form 4 insider transaction
McKechnie Duncan sold 2,437 shares of Vertex Pharmaceuticals Incorporated at $475.30 per share, a transaction worth $1.16M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,437
Price
$475.30
Total value
$1.16M
InsiderMcKechnie Duncan
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 4, 2026
Filing dateMarch 6, 2026
Shares owned after15,122
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.